NeoPhotonics Corp (NYSE: NPTN) reported first-quarter revenue in-line with the consensus estimate Thursday, while missing expectations on the EPS front.
With its 400G product expected to ramp only in 2020, the company is unlikely to deliver any meaningful revenue acceleration in the second half of 2019 due to some uncertainties surrounding U.S. data center interconnect spend, according to Rosenblatt Securities.
Demand from China has remained healthy in the first half 2019, Zhang said in a Friday note. (See his track record here.)
China Telecom has announced a tender that entails around 50,000 100G ports, and Huawei is likely to have obtained an additional 25,000 100G ports, the analyst said.
These developments will likely have a positive impact on NeoPhotonics in the third quarter of the calendar year, Zhang said.
China’s growth in demand for 100G ports could decelerate in the second half, the analyst said. Rosenblatt's forecast for 100G demand was based on the current tender pipeline and expectations of China Mobile Ltd. (NYSE: CHL) announcing a tender in May, with a potential acceleration in spending in the back half of the year, he said. Chinese demand for 100G could surpass the sell-side firm's current expectations, Zhang said.
The North American DCI market may hold uncertainty in the second half following strong growth over the last few quarters, the analyst said, adding that he expects Ciena Corporation (NYSE: CIEN) to lose market share to Acacia Communications, Inc. (NASDAQ: ACIA).
NeoPhotonics remains a strong potential acquisition target for bigger players, according to Rosenblatt.
NeoPhotonics shares were falling by 6.73 percent to $6.44 at the time of publication Friday.
MKM Out Bullish On NeoPhotonics, Cites Exposure To Optical Telecom, China
Benzinga's Top Upgrades, Downgrades For April 30, 2019
Latest Ratings for NPTN
|Apr 2019||Initiates Coverage On||Buy|
View More Analyst Ratings for NPTN
View the Latest Analyst Ratings
See more from Benzinga
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.